Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 205

    1.

    Testing the accelerator hypothesis: body size, beta-cell function, and age at onset of type 1 (autoimmune) diabetes.

    Dabelea D, D'Agostino RB Jr, Mayer-Davis EJ, Pettitt DJ, Imperatore G, Dolan LM, Pihoker C, Hillier TA, Marcovina SM, Linder B, Ruggiero AM, Hamman RF; SEARCH for Diabetes in Youth Study Group.

    Diabetes Care. 2006 Feb;29(2):290-4.PMID: 16443875 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Testing the accelerator hypothesis: the relationship between body mass and age at diagnosis of type 1 diabetes.

    Kibirige M, Metcalf B, Renuka R, Wilkin TJ.

    Diabetes Care. 2003 Oct;26(10):2865-70.PMID: 14514593 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The 'accelerator hypothesis': relationship between weight, height, body mass index and age at diagnosis in a large cohort of 9,248 German and Austrian children with type 1 diabetes mellitus.

    Knerr I, Wolf J, Reinehr T, Stachow R, Grabert M, Schober E, Rascher W, Holl RW; DPV Scientific Initiative of Germany and Austria.

    Diabetologia. 2005 Dec;48(12):2501-4. Epub 2005 Nov 11.PMID: 16283240 [PubMed - indexed for MEDLINE]Related articles

    4.

    Parameters associated with residual insulin secretion during the first year of disease in children and adolescents with Type 1 diabetes mellitus.

    Bonfanti R, Bazzigaluppi E, Calori G, Riva MC, Viscardi M, Bognetti E, Meschi F, Bosi E, Chiumello G, Bonifacio E.

    Diabet Med. 1998 Oct;15(10):844-50.PMID: 9796885 [PubMed - indexed for MEDLINE]Related articles

    5.

    [Factors affecting C-peptide level during the first year of type 1 diabetes in children]

    Zmysłowska A, Szadkowska A, Andrzejewski W, Wegner O, Wyka K, Młynarski W, Bodalski J.

    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw. 2004;10(2):103-11. Polish. PMID: 15504313 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients.

    Zanone MM, Catalfamo E, Pietropaolo SL, Rabbone I, Sacchetti C, Cerutti F, Trucco M, Cavallo-Perin P.

    Metabolism. 2003 Jan;52(1):25-9.PMID: 12524658 [PubMed - indexed for MEDLINE]Related articles

    7.

    Increasing body weight predicts the earlier onset of insulin-dependant diabetes in childhood: testing the 'accelerator hypothesis' (2).

    Betts P, Mulligan J, Ward P, Smith B, Wilkin T.

    Diabet Med. 2005 Feb;22(2):144-51.PMID: 15660730 [PubMed - indexed for MEDLINE]Related articles

    8.

    Male-to-female excess in diabetes diagnosed in early adulthood is not specific for the immune-mediated form nor is it HLA-DQ restricted: possible relation to increased body mass index.

    Weets I, Van Autreve J, Van der Auwera BJ, Schuit FC, Du Caju MV, Decochez K, De Leeuw IH, Keymeulen B, Mathieu C, Rottiers R, Dorchy H, Quartier E, Gorus FK; Belgian Diabetes Registry.

    Diabetologia. 2001 Jan;44(1):40-7.PMID: 11206410 [PubMed - indexed for MEDLINE]Related articles

    9.

    MHC class I chain-related gene-A is associated with IA2 and IAA but not GAD in Swedish type 1 diabetes mellitus.

    Gupta M, Graham J, McNeeny B, Zarghami M, Landin-Olsson M, Hagopian WA, Palmer J, Lernmark A, Sanjeevi CB.

    Ann N Y Acad Sci. 2006 Oct;1079:229-39.PMID: 17130560 [PubMed - indexed for MEDLINE]Related articles

    11.

    Successful prospective prediction of type 1 diabetes in schoolchildren through multiple defined autoantibodies: an 8-year follow-up of the Washington State Diabetes Prediction Study.

    LaGasse JM, Brantley MS, Leech NJ, Rowe RE, Monks S, Palmer JP, Nepom GT, McCulloch DK, Hagopian WA; Washingtno State Diabetes Prediction Study.

    Diabetes Care. 2002 Mar;25(3):505-11.PMID: 11874938 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Autoantibodies to the islet cell antigen SOX-13 are associated with duration but not type of diabetes.

    Davis TM, Mehta Z, Mackay IR, Cull CA, Bruce DG, Fida S, Rowley MJ, Holman RR.

    Diabet Med. 2003 Mar;20(3):198-204.PMID: 12675663 [PubMed - indexed for MEDLINE]Related articles

    13.

    Autoantibodies to ICA12 (SOX-13) are not specific for Type I diabetes.

    Steinbrenner H, Lohmann T, Ostendorf B, Scherbaum WA, Seissler J.

    Diabetologia. 2000 Nov;43(11):1381-4.PMID: 11126406 [PubMed - indexed for MEDLINE]Related articles

    14.

    Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases.

    Lindholm E, Hallengren B, Agardh CD.

    Diabetes Metab Res Rev. 2004 Mar-Apr;20(2):158-64.PMID: 15037992 [PubMed - indexed for MEDLINE]Related articles

    15.

    Major increase in Type 1 diabetes: no support for the Accelerator Hypothesis.

    O'Connell MA, Donath S, Cameron FJ.

    Diabet Med. 2007 Aug;24(8):920-3. Epub 2007 May 29.PMID: 17535289 [PubMed - indexed for MEDLINE]Related articles

    16.

    Comparison of GAD and ICA512/IA-2 antibodies at and after the onset of IDDM.

    Yokota I, Matsuda J, Naito E, Ito M, Shima K, Kuroda Y.

    Diabetes Care. 1998 Jan;21(1):49-52.PMID: 9538970 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Diabetes mellitus among young adults in Sri Lanka--role of GAD antibodies in classification and treatment: the Sri Lanka Young Diabetes study.

    Katulanda P, Shine B, Katulanda GW, Silva A, Asfir EL, Sheriff R, Somasundaram N, Long AE, Bingley PJ, McCarthy MI, Clark A, Matthews DR.

    Diabetologia. 2008 Aug;51(8):1368-74. Epub 2008 Jun 5.PMID: 18528678 [PubMed - indexed for MEDLINE]Related articles

    18.

    [C-peptide as the decisive factor for classification of type 1 diabetes mellitus and type 2 diabetes mellitus]

    Perusicová J, Bárová H, Hill M, Masek Z.

    Vnitr Lek. 2002 Jun;48(6):490-9. Czech. PMID: 12132349 [PubMed - indexed for MEDLINE]Related articles

    19.

    The PTPN22 1858T gene variant in type 1 diabetes is associated with reduced residual beta-cell function and worse metabolic control.

    Petrone A, Spoletini M, Zampetti S, Capizzi M, Zavarella S, Osborn J, Pozzilli P, Buzzetti R; Immunotherapy Diabetes (IMDIAB) Group.

    Diabetes Care. 2008 Jun;31(6):1214-8. Epub 2008 Feb 5.PMID: 18252906 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Islet autoantibodies in cord blood from patients who developed type 1 diabetes mellitus at 15-30 years of age.

    Elfving AM, Lindberg BA, Nyström L, Sundkvist G, Lernmark A, Ivarsson SA; DISS Study Group.

    Autoimmunity. 2003 Jun;36(4):227-31.PMID: 14563016 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data